References
Agresti, A. 1984. Analysis of Ordinal Categorical Data. New York: John Wiley.
Anthony, J.S., M.V. Haley, J.H. Manthei, R.A. Way, D.C. Burnett, B.P. Gaviola, D.R. Sommerville, R.B. Crosier, R.J. Mioduszewski, E.M. Jakubowski, J.L. Montgomery, and S.A. Thomson. 2002. Inhalation Toxicity of GF Vapor in Rats as a Function of Exposure Concentration and Duration and its Potency Comparison to GB. Late-breaking poster presented at 41st Annual Meeting of the Society of Toxicology, March 21, 2002, Nashville, TN.
Atherley, G. 1985. A critical review of time-weighted average as an index of exposure and dose, and of its key elements. Am. Ind. Hyg. Assoc. J. 46(9):481-487.
Baker, D.J., and E.M. Sedgwick. 1996. Single fibre electromyographic changes in man after organophosphate exposure. Hum. Exp. Toxicol. 15(5):369-375.
Benschop, H.R., and L.P.A. DeJong. 2001. Toxicokinetics of nerve agents. Pp. 25-81 in Chemical Warfare Agents: Toxicity at Low Levels, S.M. Somani, and J.A. Romano, eds. Boca Raton, FL: CRC Press.
Black, R.M., R.J. Clarke, J.M. Harrison, and R.W. Read. 1997. Biological fate of sulfur mustard: Identification of valine and histidine adducts in haemoglobin from casualties of sulfur mustard poisoning. Xenobiotica 27(5):499-512.
Blick, D.W., M.R. Murphy, G.C. Brown, M.G. Yochmowitz, J.W. Fanton, and S.L. Hartgraves. 1994. Acute behavioral toxicity of pyri-
dostigmine or soman in primates. Toxicol. Appl. Pharmacol. 126(2):311-318.
Bomser, J.A., and J.E. Cassida. 2001. Diethylphosphorylation of rat cardiac M2 muscarinic receptor by chlorpyrifos oxon in vitro. Toxicol. Lett. 119(1):21-26.
Bonderman, R.P., and D.P. Bonderman. 1971. Atypical and inhibited human serum pseudocholinesterase: A titrimetric method for differentiation. Arch. Environ. Health 22(5):578-581.
Brown, M.A., and K.A. Brix. 1998. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J. Appl. Toxicol. 18(6):393-408.
Bucci, T.J., R.M. Parker, and P.A. Gosnell. 1992a. Toxicity Studies on Agents GB and GD (Phase II): Delayed Neuropathy Study of Soman in SPF White Leghorn Chickens. AD-A257183. Prepared for the U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, MD, by the National Center for Toxicological Research, Jefferson, AR.
Bucci, T.J., R.M. Parker, J.A. Crowell, J.D. Thurman, and P.A. Gosnell. 1992b. Toxicity Studies on Agent GA (Phase II): 90 Day Subchronic Study of GA (Tabun) in CD Rats. Final Report. AD-A258020. Prepared for the U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, MD, by the National Center for Toxicological Research, Jefferson, AR.
Burchfiel, J.L., F.H. Duffy, and M. van Sim. 1976. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol. Appl. Pharmacol. 35(2):365-379.
Castro, C.A., V.C. Gresham, A.V. Finger, D.M. Maxwell, R.P. Solana, and D.E. Lenz. 1994. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicol. Teratol. 16(2):145-148.
CBIAC (Chemical and Biological Defense Information Analysis Center). 1995. Worldwide Chemical Detection Equipment Handbook. HB-95-02. CBIAC Gunpowder Branch Aberdeen Proving Ground, MD.
CBIAC (Chemical and Biological Defense Information Analysis Center). 1998a. The Emergency Responder’s Ability to Detect Chemical Agents. CR-98-06. CBIAC Gunpowder Branch Aberdeen Proving Ground, MD.
CBIAC (Chemical and Biological Defense Information Analysis Center). 1998b. Assessment of Chemical Detection Equipment for Hazmat Responders. SOAR-98-05. CBIAC Gunpowder Branch Aberdeen Proving Ground, MD.
Chemical Casualty Care Office. 1995. Medical Management of Chemical Casualties Handbook, 2nd Ed. Chemical Casualty Care Office, Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. [Online]. Available: http://www.fas.org/nuke/guide/usa/doctrine/army/mmcch/ [accessed June 16, 2004].
Chilcott, R.P., C.H. Dalton, I. Hill, C.M. Davidson, K.L. Blohm, and M.G. Hamilton. 2003. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exp. Toxicol. 22(5):255-261.
Clement, J.G. 1994. Toxicity of the combined nerve agents GB/GF in mice: Efficacy of atropine and various oximes as antidotes. Arch. Toxicol. 68(1):64-66.
Diggle, P., K.Y. Liang, and S.L. Zeger. 1994. Analysis of Longitudinal Data. Oxford, England: Clarendon Press.
DOD (U.S. Department of Defense). 2003. Low-Level Chemical Warfare Agents (CWAs) Exposure Research Master Plan. June 2003.
Duffy, F.H., J.L. Burchfiel, P.H. Bartels, M. Gaon, and V.M. Sim. 1979. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol. Appl. Pharmacol. 47(1):161-176.
EPA (U.S. Environmental Protection Agency). 2000. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures. EPA/630/R-00/002. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. August 2000. [Online]. Available: http://www.epa.gov/ncea/raf/pdfs/chem_mix/chem_mix_08_2001.pdf [accessed June 21, 2004].
EPA (U.S. Environmental protection Agency). 2003. Catreg Software for Categorical Regression Analysis. National Center For Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park Office, Research Triangle Park, NC [online]. Available: http://permanent.access.gpo.gov/lps35390/cfpub.epa.gov/ncea/cfm/recordisplay.cfmdeid=18162.htm [accessed Sept. 14, 2005].
EPA (U.S. Environmental Protection Agency). 2004. Glossary of IRIS Terms. Integrated Risk Information System, U.S. Environmental Protection Agency. [Online]. Available: http://www.epa.gov/iris/gloss8.htm#c [accessed May 2004].
Ferraro, F.R., and M. Gabriel. 2003. Preservation of implicit memory in adult children of alcoholics. J. Psychol. 137(4):373-380.
Fidder, A., A.G. Hulst, D. Noort, R. de Ruiter, M.J. van der Schans, H.P. Benschop, and J.P. Langenberg. 2002. Retrospective detection of exposure to organophosphorus anti-cholinesterases: Mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 15(4):582-590.
Furlong, C.E., W.F. Li, D.M. Shih, A.J. Lusis, R.J. Richter, and L.G. Costa. 2002. Genetic factors in susceptibility: Serum PON1 variation between individuals and species. Hum. Ecol. Risk Asses. 8(1):31-44.
GAO (U.S. Government Accounting Office). 1998. Chemical Weapons: DOD Does Not Have a Strategy to Address Low-Level Exposures: Report to Congressional Requestors. GAO/NSIAD-98-228. Washington, DC: U.S. Government Accounting Office. September 1998.
Gaylor, D.W., and W. Slikker, Jr. 1990. Risk assessment for neurotoxic effects. Neurotoxicology 11(2):211-218.
Gearhart, J.M., G.W. Jepson, H.J. Clewell, III, M.E. Andersen, and R.B. Conolly. 1990. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 106(2):295-310.
Gearhart, J.M., G.W. Jepson, H.J. Clewell, M.E. Andersen, and R.B. Conolly. 1994. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters. Environ. Health Perspect. 102(Suppl. 11):51-60.
Gentry, P.R., C.E. Hack, L. Haber, A. Maier, and H.J. Clewell III. 2002. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70(1):120-139.
Goldman, M., A.K. Klein, T.G. Kawakami, and L.S. Rosenblatt. 1987. Toxicity Studies on Agents GB (Sarin-Types I and II) and GD (Soman), Final Report. AD-A187841. Prepared for U.S. Army Medical Research and Development Command, Fort Detrick, MD, by Laboratory for Energy-Related Health Research, University of California, Davis.
Gray, P.J., and R.M. Dawson. 1987. Kinetic constants for the inhibition of eel and rabbit brain acetylcholinesterase by some organopho-
phates and carbamates of military significance. Toxicol. Appl. Pharmacol. 91(1):140-144.
Grotte, J.H., and I.L. Yang. 2001. Report of the Workshop on Chemical Agent Toxicity for Acute Effects, May 11-12, 1998, Institute for Defense Analysis. IDA Document D-2176. Institute for Defense Analyses. Alexandria, VA [Online]. Available: https://usachppm.apgea.army.mil/chemicalagent/caw/IDAreport(2001).pdf [accessed June 16, 2004].
Gurevitch, J., and L.V. Hedges. 1993. Meta-analysis: Combining the results of independent experiments. Pp. 378-401 in Design and Analysis of Ecological Experiments, S.M. Schenier, and J. Gurevitch, eds. London: Chapman and Hall.
Guth, D.J., R.J. Carroll, D.G. Simpson, and H. Zhou. 1997. Categorical regression analysis of acute exposure to tetrachloroethylene. Risk Anal. 17(3):321-332.
Haber, L., J.A. Strickland, and D.J. Guth. 2001. Categorical regression analysis of toxicity data. Comments Toxicol. 7(5/6):437-452.
Hartgraves, S.L., and M.R. Murphy. 1992. Behavioral effects of low-dose nerve agents. Pp. 125-154 in Chemical Warfare Agents, S.M. Somani, ed. San Diego, CA: Academic Press.
Hayes, W.J. 1982. Pesticides Studied in Man. Baltimore, MD: Lippincott William and Wilkins.
Hedges, L.V., and I. Olkin. 1985. Statistical Methods for Meta Analysis. Orlando, FL: Academic Press.
Henderson, R.F., E.B. Barr, W.B. Blackwell, C.R. Clark, C.A. Conn, R. Kalra, T.H. March, M.L. Sopori, Y. Tesfaigzi, M.G. Ménache, and D.C. Mash. 2002. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 184(2):67-76.
Hertzberg, R.C. 1989. Fitting a model to categorical response data with application to species extrapolation of toxicity. Health Phys. 57(Suppl. 1):405-409.
Hertzberg, R.C., and M. Miller. 1985. A statistical model for species extrapolation using categorical response data. Toxicol. Ind. Health 1(4):43-57.
Himuro, K., S. Murayama, K. Nishiyama, T. Shinoe, H. Iwase, M. Nagao, T. Takatori, and I. Kanazawa. 1998. Distal sensory axonopathy after sarin intoxication. Neurology 51(4):1195-1197.
Howard, M.D., and C.N. Pope. 2002. In vitro effects of chlorpyrifos, parathion, methyl parathion and their oxons on cardiac muscarinic
receptor binding in neonatal and adult rats. Toxicology 170(1-2):1-10.
IPCS (International Programme on Chemical Safety). 2001. Guidance Document for the Use of Data in Development of Chemical-Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability in Dose/Concentration Response Assessment. WHO/PCS/01.4. World Health Organization, Geneva [Online]. Available: http://www.who.int/pcs/harmon_site/harmonize/docs/Guidance_Doc.pdf [accessed June 16, 2004].
Jarabek, A.M. 1995. Consideration of temporal toxicity challenges current default assumptions. Inhal. Toxicol. 7:927-946.
Kant, G.J., T.M. Shih, E.W. Bernton, H.G. Fein, R.C. Smallridge, and E.H. Mougey. 1991. Effects of soman on neuroendocrine and immune function. Neurotoxicol. Teratol. 13(2):223-228.
LaBorde, J.B., and H.K. Bates. 1986. Developmental Toxicity Study of Agent GB-DCSM Types I and II in NZW Rabbits, Final Report. AD-A168331/7. Prepared for U.S. Army Medical Research and Development Command, Fort Detrick, MD, by National Center for Toxicological Research, Jefferson, AR.
Langenberg, J.P., C. van Dijk, R.E. Sweeney, D.M. Maxwell, L.P. De Jong, and H.P. Benschop. 1997. Development of a physiologically based model for the toxicokinetics of C(+/−)P(+/−)−soman in the atropinized guinea pig. Arch. Toxicol. 71(5):320-331.
Luo, C., and J. Liang. 1997. Evaluation of the combined toxic effects of GB/GF and efficacy of Jielin injection against combined poisoning in mice. Toxicol. Lett. 92(3):195-200.
Manly, B.F.J. 2001. Statistics for Environmental Science and Management. Boca Raton, FL: Chapman & Hall/CRC.
Maxwell, D.M., C.P. Vlahacos, and D.E. Lenz. 1988. A pharmacodynamic model for soman in the rat. Toxicol. Lett. 43(1-3):175-188.
McCullagh, P., and J.A. Nelder. 1989. Generalized Linear Models, 2nd Ed. London: Chapman & Hall.
McDonough, J.H., and T.M. Shih. 1997. Neuropharmacological mechanisms of nerve agent-induced neuropathology. Neurosci. Biobehav. Rev. 21(5):559-579.
Metcalf, D.R., and J.H. Holmes. 1969. VII. Toxicology and physiology. EEG, psychological and neurological alterations in humans with organophosphorus exposure. Ann. N.Y. Acad. Sci. 160(1): 357-365.
Mioduszewski, R.J., S.A. Reuter, L.L. Miller, E.J. Olajos, and S.A. Thompson. 1998. Evaluation of Airborne Exposure Limits for G-Agents: Occupational and General Population Exposure Criteria. AD-A345618/3. ERDEC-TR-489. Edgewood Research, Development and Engineering Center, U.S. Army Chemical and Biological Defense Command, Aberdeen Proving Ground, MD [Online]. Available: http://chppm-www.apgea.army.mil/chemicalagent/caw/ERDEC-TR-489.pdf [accessed Sept. 22, 2004].
Mioduszewski, R.J., J. Manthei, R. Way, D. Burnett, B. Gaviola, W. Muse, S. Thomson, D. Sommerville, and R. Crosier. 2000. Estimating the probability of sarin vapor toxicity in rats as a function of exposure concentration and duration. Proceedings of the International Chemical Weapons Demilitarization Conference (CWD-2000), May 21-24, 2000, The Hague, Netherlands.
Mioduszewski, R.J., J. Manthei, R. Way, D. Burnett, B. Gaviola, W. Muse, J. Anthony, D. Durst, D. Sommerville, R. Crosier, S. Thomson, and C. Crouse. 2001. ECBC Low Level Operational Toxicology Program: Phase I-Inhalation toxicity of Sarin Vapor in Rats as a Function of Exposure Concentration and Duration. ECBC-TR-183. Edgewood Research Development and Engineering Center, Aberdeen Proving Ground, MD. August 2001.
Mioduszewski, R.J., J. Manthei, R. Way, D. Burnett, B. Gaviola, W. Muse, S. Thomson, D. Sommerville, and R. Crosier. 2002a. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 66(2):176-184.
Mioduszewski, R.J., J. Manthei, R. Way, D. Burnett, B. Gaviola, W. Muse, S. Thomson, D. Sommerville, R. Crosier, J. Scotto, D. McCaskey, C. Crous, and K. Matson. 2002b. Low-Level Sarin Vapor Exposure in Rats: Effect of Exposure Concentration and Duration on Pupil Size. ECBC-TR-235. Edgewood Chemical Biological Center, U.S. Army Soldier and Biological Chemical Command, Aberdeen Proving Ground, MD. May 2002.
Moore, D. 1998. Health effects of exposure to low doses of nerve agent- A review of present knowledge. Drug Chem. Toxicol. 21(Suppl. 1):123-130.
Morita, H., N. Yanagisawa, T. Nakajima, M. Shimizu, H. Hirabayashi, H. Okudera, M. Nohara, Y. Midorikawa, and S. Mimura. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 346(8970):290-293.
Murata, K., S. Araki, K. Yokoyama, T. Okumura, S. Ishimatsu, N. Takasu, and R.F. White. 1997. A-symptomatic sequelae to acute sa-
rin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J. Neurol. 244(10):601-606.
Murphy, M.R., D.W. Blick, M.A. Dunn, J.W. Fanton, and S.L. Hartgraves. 1993. Diazepam as a treatment for nerve agent poisoning in primates. Aviat. Space Environ. Med. 64(2):110-115.
Myers, T.M., G. Galbicka, M.L. Sipos, S. Varadi, J.L. Oubre, and M.G. Clark. 2002. Effects of anticholinergics on serial-probe recognition accuracy of rhesus macaques (Macaca mulatta). Pharmacol. Biochem. Behav. 73(4):829-834.
Nakajima, T., S. Sato, H. Morita, and N. Yanagisawa. 1997. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup. Environ. Med. 54(10):697-701.
Nakajima, T., S. Ohta, H. Morita, Y. Midorikawa, S. Mimura, and N. Yanagisawa. 1998. Epidemiological study of sarin poisoning in Matsumoto City, Japan. J. Epidemiol. 8(1):33-41.
Nakajima, T., S. Ohta, Y. Fukushima, and N. Yanagisawa. 1999. Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan. J. Epidemiol. 9(5):337-343.
Neter, J., M.H. Kutner, C.J. Nachtsheim, and W. Wasserman. 1996. Applied Linear Statistical Models, 4th Ed. Chicago, IL: Irwin Press.
Noort, D., A.G. Hulst, H.C. Trap, L.P. De Jong, and H.P. Benschop. 1997. Synthesis and mass spectrometric identification of the major amino acid adduct formed between sulphur mustard and haemoglobin in human blood. Arch. Toxicol. 71(3):171-178.
Noort, D., A.G. Hulst, and R. Jansen. 2002. Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin. Arch. Toxicol. 76(2):83-88.
NRC (National Research Council). 1982. Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents, Vol. 1. Anticholinesterases and Anticholinergics. Washington, DC: National Academy Press.
NRC (National Research Council). 1985. Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents, Vol. 3: Final Report, Current Health Status of Test Subjects. Washington, DC: National Academy Press.
NRC (National Research Council). 1989. Report of the Oversight Committee. Pp. 15-35 in Biologic Markers in Reproductive Toxicology. Washington, DC: National Academy Press.
NRC (National Research Council). 1993. Guidelines for Developing Community Emergency Exposure Levels for Hazardous Substances. Washington, DC: National Academy Press.
NRC (National Research Council). 1999. Review of the U.S. Army’s Health Risk Assessment for Oral Exposure to Six Chemical Warfare Agents. Washington, DC: National Academy Press.
NRC (National Research Council). 2000. Strategies to Protect the Health of Deployed U.S. Forces: Analytic Framework for Assessing Risks. Washington, DC: National Academy Press.
NRC (National Research Council). 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: National Academy Press.
NRC (National Research Council). 2003. Acute Exposure Guideline Levels for Selected Airborne Chemicals, Vol. 3. Washington, DC: The National Academies Press.
NRC (National Research Council). 2004. Review of the Army’s Technical Guides on Assessing and Managing Chemical Hazards to Deployed Personnel. Washington, DC: The National Academies Press.
O’Hern, M.R., T.R. Dashiell, and M.F. Tracy. 1997. Chemical defense equipment. Pp. 361-392 in Medical Aspects of Chemical and Biological Warfare, F.R. Sidell, E.T. Takafuji, and D.R. Franz, eds. Textbook of Military Medicine, Part 1. Warfare, Weaponry, and the Casualty, Vol. 3. Borden Institute, Walter Reed Army Medical Center, Washington, DC; Office of The Surgeon General U.S. Army, Falls Church, VA; U.S. Army Medical Department Center and School, Fort Sam Houston, TX; U.S. Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD; and Uniformed Services University of the Health Sciences, Bethesda, MD.
Okudera, H. 2002. Clinical features on nerve gas terrorism in Matsumoto. J. Clin. Neurosci. 9(1):17-21.
Page, W.F. 2003. Long-term health effects of exposure to sarin and other anticholinesterase chemical warfare agents. Mil. Med. 168(3):239-245.
Piegorsch, W.W. 1998. Statistical aspects for combining information and meta-analysis in environmental toxicology. J. Environ. Sci. Health C Environ. Carcinogenesis Ecotoxicol. Rev. C16(2):83-89.
Polhuijs, M., J.P. Langenberg, and H.P. Benschop. 1997. New method for retrospective detection of exposure to organophosphorus anti-
cholinesterases: Application to alleged sarin victims of Japanese terrorists. Toxicol. Appl. Pharmacol. 146(1):156-161.
Presidential Advisory Committee on Gulf War Veterans’ Illnesses. 1996. Final Report. Washington, DC: U.S. Government Printing Office.
Ray, D.E. 1998. Chronic effects of low level exposure to anticholinesterases—a mechanistic review. Toxicol. Lett. 102/103:527-533.
Rengstorff, R.H. 1994. Vision and ocular changes following accidental exposure to organophosphates. J. Appl. Toxicol. 14(2):115-118.
Robbins, T.W. 2002. The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. Psychopharmacology 163(3-4):362-380.
Robineau, P., Y. Leclercq, A. Gerbi, I. Berrebi-Bertrand, and L.G. Lelievre. 1991. An organophosphorus compound, VX, selectively inhibits the rat cardiac Na+, K(+)-ATPase alpha 1 isoform. Biochemical basis of the cardiotoxicity of VX. FEBS Lett. 281(1-2):145-148.
Romano, J., J. McDonough, R. Sheridan, and F. Sidell. 2001. Health effects of low-level exposure to nerve agents. Pp. 1-24 in Chemical Warfare Agents: Toxicity at Low Levels, S.M. Somani, and J.A. Romano, eds. Boca Raton, FL: CRC Press.
Senanayake, N., and L. Karalliedde. 1987. Neurotoxic effects of organophosphate insecticides: An intermediate syndrome. N. Engl. J. Med. 316(13):761-763.
Shih, M.L., J.D. McMonagle, T.W. Dolzine, and V.C. Gresham. 1994. Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents. J. Appl. Toxicol. 14(3):195-199.
Sidell, F.R. 1974. Soman and sarin: Clinical manifestations and treatment of accidental poisoning by organophosphates. Clin. Toxicol. 7(1):1-17.
Sidell, F. 1992. Clinical considerations in nerve agent intoxication. Pp. 156-194 in Chemical Warfare Agents, S.M. Somani, ed. San Diego, CA: Academic Press.
Sidell, F.R. 1997. Nerve agents. Pp. 129-180 in Medical Aspects of Chemical and Biological Warfare, F.R. Sidell, E.T. Takafuji, and D.R. Franz, eds. Textbook of Military Medicine, Part 1. Warfare, Weaponry, and the Casualty, Vol. 3. Borden Institute, Walter Reed Army Medical Center, Washington, DC; Office of The Surgeon General U.S. Army, Falls Church, VA; U.S. Army Medical De-
partment Center and School, Fort Sam Houston, TX; U.S. Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD; and Uniformed Services University of the Health Sciences, Bethesda, MD.
Sidell, F.R., and C.G. Hurst. 1997. The long-term health effects of nerve agents and mustard. Pp. 229-246 in Medical Aspects of Chemical and Biological Warfare, F.R. Sidell, E.T. Takafuji, and D.R. Franz, eds. Textbook of Military Medicine, Part 1. Warfare, Weaponry, and the Casualty, Vol. 3. Borden Institute, Walter Reed Army Medical Center, Washington, DC; Office of The Surgeon General U.S. Army, Falls Church, VA; U.S. Army Medical Department Center and School, Fort Sam Houston, TX; U.S. Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD; and Uniformed Services University of the Health Sciences, Bethesda, MD.
Somani, S.M., and K. Husain. 2001. Low-level nerve agent toxicity under normal and stressful conditions. Pp. 83-120 in Chemical Warfare Agents: Toxicity at Low Levels, S.M. Somani, and J.A. Romano, eds. Boca Raton, FL: CRC Press.
Spencer, P.S., B.W. Wilson, and E.X. Albuquerque. 2000. Sarin other “nerve agents,” and their antidotes. Pp. 1073-1093 in Experimental and Clinical Neurotoxicology, 2nd Ed., P.S. Spencer, and H.H. Schaumburg, eds. New York: Oxford University Press.
ten Berge, W.F., A. Zwart, and L.M. Appelman. 1986. Concentration-time mortality response relationship of irritant and systematically acting vapors and gases. J. Hazard. Mater. 13(3):301-309.
USACHPPM (U.S. Army Center for Health Promotion and Preventive Medicine). 2002a. Chemical Exposure Guidelines for Deployed Military Personnel. Technical Guide 230. U.S. Army Center for Health Promotion and Preventive Medicine. January 2002. [Online]. Available: http://chppm-www.apgea.army.mil/deployment/ [accessed June 21, 2004]
USACHPPM (U.S. Army Center for Health Promotion and Preventive Medicine). 2002b. Chemical Exposure Guidelines for Deployed Military Personnel. A Companion Document to USACHPPM Technical Guide (TG) 230 Chemical Exposure Guidelines for Deployed Military Personnel. Reference Document (RD) 230. US. Army Center for Health Promotion and Preventive Medicine. January 2002.
U.S. Department of the Army. 1998. Risk Management. Army Field Manual 100-14. Headquarters, Department of the Army, Washington, DC. April 23, 1998.
van der Schans, G.P., D. Noort, R.H. Mars-Groenendijk, A. Fidder, L.F. Chau, L.P. de Jong, and H.P. Benschop. 2002. Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin. Chem. Res. Toxicol. 15(1):21-25.
van Helden, H.P.M., J.P. Langenberg, and H.P. Benschop. 2001. Low Level Exposure to GB Vapor in Air: Diagnosis/Dosimetry, Lowest Observable Effect Levels, and Performance Incapacitation. Final Report Grant Agreement DAMD17-97-1-7360. NTIS ADA400785. Prepared for U.S. Army Medical Research and Materiel Command, Fort Detrick, MD, by Prins Maurits Laboratory, TNO, Rijswijk, the Netherlands. April 2001.
van Helden, H.P.M., H.C. Trap, W.C. Kuijpers, B. Groen, J.P. Oostdijk, R.A.P. Vanwersch, I.H.C. Philippens, J.P. Langenberg, and H.P. Benschop. 2002. Low Level Exposure to GB Vapor in Air: Diagnosis/Dosimetry, Lowest Observable Effect Level, and Performance-Incapacitation. Operational Medical Issues in Chemical and Biological Defense [RTO-MP-075, AC/323(HFM-060)TP/37], North Atlantic Treaty Organisation, Research and Technology Organisation Symposium, 14-17 May 2001, Estoril, Portugal.
van Helden, H.P.M, H.C. Trap, J.P. Oostdijk, W.C. Kuijpers, J.P. Langenberg, and H.P. Benschop. 2003. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: Lowest observable effect level. Toxicol. Appl. Pharmacol. 189(3):170-179.
Verbeke, G., and G. Molenberghs, eds. 1997. Linear Mixed Models in Practice: A SAS-Oriented Approach. Lecture Notes in Statistics 126. New York: Springer.
Wolfe, A.D., D.W. Blick, M.R. Murphy, S.A. Miller, M.K. Gentry, S.L. Hartgraves, and B.P. Doctor. 1992. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117(2):189-193.
Yanno, L.V., and Y.U. Musiichuk. 1997. Neuroparalytic agent acute poisoning and its long- term effects. [in Russian]. Med. Tr. Prom. Ecol. (6):5-7.
Yokoyama, K., S. Araki, K. Murata, M. Nishikitani, T. Okumura, S. Ishimatsu, N. Takasu, and R.F. White. 1998a. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to
post-traumatic stress disorders. Arch. Environ. Health 53(4):249-256.
Yokoyama, K., S. Araki, K. Murata, M. Nishikitani, T. Okumura, S. Ishimatsu, and N. Takasu. 1998b. A preliminary study on delayed vestibulo-cerebellar effects of Tokyo Subway Sarin Poisoning in relation to gender difference: Frequency analysis of postural sway. J. Occup. Environ. Med. 40(1):17-21.
Young, R.A., D.M. Opresko, A.P. Watson, R.H. Ross, J. King, and H. Choudhury. 1999. Deriving toxicity values for organophosphate nerve agents: A position paper in support of the procedures and rationale for deriving oral RfDs for chemical warfare nerve agents. J. Hum. Ecol. Risk Asses. 5(3):589-634.
Yu, K.O, R.J. Mioduszewski, E.M. Jakubowski, S. Hulet, S.M. Thompson, and J.M. Gearhart. 2004. Preliminary development of physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model for low level exposure to chemical warfare agent (CWA) in mini pig. Abstract 2035. Toxicologist 78(S-1):419.
